QBiotics receives first registration for tigilanol tiglate wit...
BRISBANE, Australia, Jan. 20, 2020 /PRNewswire-AsiaNet/ -- - STELFONTA(R) (tigilanol tiglate) approved by the European Medicines Agency (EMA), making it the first pharmaceutical treatment available for all grades of canine non-metastatic mast cell tumours (MCT)[1] - The approval marks the first registra...
Authors: LATEST ASIANET NEWS RELEASES